The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...

HealthEquity (HQY) reports strong Q1 2026 growth with increased revenue, reduced fraud costs, and advancements in AI and mobile tech.

Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Prudential (PRU) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...